The Oxford Ovarian Cancer Predict Chemotherapy Response (OXO-PCR) study: Understanding the genomic drivers of primary chemotherapy-resistant microscopic residual disease
Artibani M., Mallett G., Sunanda D., KaramiNejadRanjbar M., Morotti M., ElSahhar S., Sauka-Spengler T., Ahmed AA.